Skip to main content

Teva stock plummets 11% as generics turnaround looks uncertain

Company leadership has talked about generic prices stabilizing, but new remarks on Thursday cast that hope in an uncertain light.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.